@article{7460643ec085418fa05530c79746f123,
title = "Gender equity in interstitial lung disease",
author = "Leticia Kawano-Dourado and Glassberg, {Marilyn K.} and Maria Molina-Molina and Strek, {Mary E.} and Marlies Wijsenbeek and Johannson, {Kerri A.}",
note = "Funding Information: MKG serves on the advisory board for Bellerophon Therapeutics. MM-M reports grants and personal fees from Boehringer Ingelheim, Esteve-Teijin, and Roche; personal fees from Galapagos and Pfizer; and grants from GlaxoSmithKline, outside of the submitted work. MES reports grants, personal fees, and non-financial support from Boehringer Ingelheim and grants from Galapagos and Novartis, outside of the submitted work. MW's institution received grants and consultancy fees from Boehringer Ingelheim and Hoffmann-La Roche, and consultancy fees from Galapagos, Novartis, and Respivant, outside of the submitted work. KAJ reports she has served as a consultant to and received personal fees from Blade Therapeutics, Boehringer Ingelheim, Hoffmann-La Roche, and Theravance; grants from Chest Foundation, University of Calgary School of Medicine, Pulmonary Fibrosis Society of Calgary, and UCB Biopharma SPRL; and personal fees from Three Lakes Foundation, outside of the submitted work. LK-D declares no competing interests. ",
year = "2020",
month = sep,
doi = "10.1016/S2213-2600(20)30310-6",
language = "English (US)",
volume = "8",
pages = "842--843",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "Elsevier Ltd",
number = "9",
}